Bank of America’s Viela Bio, Inc. Common Stock VIE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-5,183
Closed -$187K 8042
2020
Q4
$187K Sell
5,183
-13,009
-72% -$456K ﹤0.01% 5643
2020
Q3
$511K Buy
18,192
+9,220
+103% +$326K ﹤0.01% 4696
2020
Q2
$388K Buy
8,972
+7,693
+601% +$348K ﹤0.01% 4800
2020
Q1
$48K Buy
1,279
+432
+51% +$16.8K ﹤0.01% 5891
2019
Q4
$23K Buy
+847
New +$21.3K ﹤0.01% 6477

Bank of America's VIE Position: Q1 2021 in Review

Bank of America sold out of Viela Bio, Inc. Common Stock (VIE) in Q1 2021, closing a stake of 5,183 shares — an estimated $187K sold.

Bank of America first reported a position in VIE in Q4 2019 and held it in 5 quarters. The position peaked at $511K in Q3 2020. 0 funds tracked by Wall St. Rank hold VIE as of Q1 2021.

  • Bank of America reported no remaining Viela Bio, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Bank of America sold 5,183 Viela Bio, Inc. Common Stock shares in Q1 2021, an estimated $187K.
  • Bank of America first reported a position in Viela Bio, Inc. Common Stock in Q4 2019 and held it in 5 quarters.
  • Bank of America's Viela Bio, Inc. Common Stock position peaked at $511K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Viela Bio, Inc. Common Stock as of Q1 2021.

Based on Bank of America's 13F filing for Q1 2021, filed 14 May 2021.